友情提示：以下期刊信息可能会有更新，仅供参考，请在投稿前自行登录期刊官网仔细核实。
期刊名
Cancer Cell International
CANCER CELL INT
ISSN / eISSN
1475-2867 / 1475-2867
目标和范围
Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques.
The journal focuses on novel cancer studies reporting data from biological experiments performed on cells grown in vitro, in two- or three-dimensional systems, and/or in vivo (animal experiments). These types of experiments have provided crucial data in many fields, from cell proliferation and transformation, to epithelial-mesenchymal interaction, to apoptosis, and host immune response to tumors.
Cancer Cell International also considers articles that focus on novel technologies or novel pathways in molecular analysis and on epidemiological studies that may affect patient care, as well as articles reporting translational cancer research studies where in vitro discoveries are bridged to the clinic. As such, the journal is interested in laboratory and animal studies reporting on novel biomarkers of tumor progression and response to therapy and on their applicability to human cancers.
The journal focuses on novel cancer studies reporting data from biological experiments performed on cells grown in vitro, in two- or three-dimensional systems, and/or in vivo (animal experiments). These types of experiments have provided crucial data in many fields, from cell proliferation and transformation, to epithelial-mesenchymal interaction, to apoptosis, and host immune response to tumors.
Cancer Cell International also considers articles that focus on novel technologies or novel pathways in molecular analysis and on epidemiological studies that may affect patient care, as well as articles reporting translational cancer research studies where in vitro discoveries are bridged to the clinic. As such, the journal is interested in laboratory and animal studies reporting on novel biomarkers of tumor progression and response to therapy and on their applicability to human cancers.
研究方向
肿瘤学
CiteScore
10.90
查看趋势图
CiteScore 学科排名
| 类别 | 分区 | 排名 |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology - Genetics | Q1 | #37/347 |
| Biochemistry, Genetics and Molecular Biology - Oncology | Q1 | #52/404 |
| Biochemistry, Genetics and Molecular Biology - Cancer Research | Q1 | #45/230 |
Web of Science 核心收藏夹
| Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
|---|---|
| Indexed | - |
| 类别 (Journal Citation Reports 2024) | 分区 |
|---|---|
| ONCOLOGY | Q1 |
H-index
47
出版国家或地区
ENGLAND
出版商
BioMed Central
出版周期
Irregular
出版年份
2001
年文章数
314
Open Access
YES
通讯方式
BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL
认证评论
Submission overview:
Submitted in mid-May 2020, received peer review by the end of June.
Three reviewers provided over 20 questions: varying levels of difficulty, including additional experiments. Generally speaking, the feedback was fair and reasonable.
The initial revision time given by the editor was one month, but it was delayed by two months due to personal reasons.
The second round of review was fast, taking approximately three days, and then the paper was accepted.
The suggestion for payment of publication fees is to go to the Bank of China, where the staff are experienced in handling such matters and it takes about half an hour.
Overall, the editor's response to emails was prompt, the peer review process took one month, and the overall quality of the paper was satisfactory.
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now